With U.S. arch rival Eli Lilly streaking away on weight-loss prescriptions and valuation, the last thing Novo Nordisk needed ...

"The Jeffersons" star Marla Gibbs reveals surviving a devastating brain aneurysm and stroke in 2006, sharing her inspiring ...

Eli Lilly's financial results should remain strong through economic and market downturns. The company's deep pipeline should help power growth beyond the current GLP-1 cycle. Eli Lilly has ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...

The new KwikPen holds four weekly doses.

Eli Lilly announced on " Good Morning America " Monday that its GLP-1 weight-loss drug Zepbound will now be available in a ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...

Mobile stroke units (MSU) enable rapid identification and treatment of thrombolytic-eligible patients with acute ischemic stroke (AIS). Recent studies have highlighted the benefit of MSUs over ...

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

More than 1.6 million adults in ­England, Wales and Scotland used weight-loss drugs such as Wegovy and Mounjaro between early 2024 and early 2025.

You've seen plenty of weird engines on Jalopnik, from Trojan's weird two-stroke, four-cylinder cube with wishbone-shaped connecting rods to the Napier Deltic triangle-18 diesel, but never have you ...